Search results
Tasuku Honjo (本庶 佑, Honjo Tasuku, born January 27, 1942) is a Japanese physician-scientist and immunologist. He won the 2018 Nobel Prize in Physiology or Medicine and is best known for his identification of programmed cell death protein 1 (PD-1). [3]
Tasuku Honjo is a Japanese immunologist who discovered a protein that inhibits the immune system. He shared the Nobel Prize in Physiology or Medicine 2018 with James Allison for their discovery of cancer therapy by inhibition of negative immune regulation.
Jun 17, 2024 · Tasuku Honjo, Japanese immunologist who contributed to the discovery of mechanisms and proteins critical to the regulation of immune responses and whose work led to the development of novel immunotherapies against cancer. Honjo received a share of the 2018 Nobel Prize for Physiology or Medicine.
- Kara Rogers
Oct 1, 2018 · Tasuku Honjo discovered PD-1, a protein that functions as a brake on T cells, and developed it into a new strategy for cancer therapy. He shared the Nobel Prize in Physiology or Medicine with James P. Allison, who discovered CTLA-4, another T-cell brake.
Tasuku Honjo is a distinguished professor and deputy director-general of KUIAS, and a Nobel laureate in medicine for his discovery of PD-1. He has also made significant contributions to molecular immunology, class switch recombination, and cancer immunotherapy.
People also ask
Who is Tasuku Honjo?
What did Tasuku Honjo discover?
What awards has Honjo won?
How did Dr Honjo contribute to developmental biology?
Oct 1, 2018 · American James Allison and Japan’s Tasuku Honjo have won the 2018 Nobel Prize in Medicine for a pioneering approach to cancer treatment. The Nobel committee said the pair’s research – which ...